Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Kimitaka, Akaike"'
Autor:
Shohei Hamada, Kei Muramoto, Kimitaka Akaike, Hiroko Okabayashi, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract It is unclear which factor Xa (FXa) inhibitors are associated with higher bleeding risk in patients with respiratory diseases, and there are no studies on the association between prothrombin time–international normalized ratio (PT–INR) a
Externí odkaz:
https://doaj.org/article/8bf2326b2c5044fbbf4f5d872e5f4581
Autor:
Kimitaka Akaike, Koichi Saruwatari, Shinya Sakata, Seitaro Oda, Shinya Shiraishi, Shinji Iyama, Aiko Masunaga, Yusuke Tomita, Hidenori Ichiyasu, Takuro Sakagami
Publikováno v:
Respirology Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Abstract Acute exacerbation of idiopathic interstitial pneumonias (AE‐IIPs) is a disease associated with a poor prognosis in patients with IIPs. However, the specific characteristics of fluorine‐18 2‐fluoro‐2‐deoxy‐d‐glucose (18F‐FDG)
Externí odkaz:
https://doaj.org/article/cf00d00df5494f42b52e74f63d38de32
Autor:
Yusuke Tomita, Yoshihiko Goto, Shinya Sakata, Kosuke Imamura, Ayaka Minemura, Kentaro Oka, Atsushi Hayashi, Takayuki Jodai, Kimitaka Akaike, Moriyasu Anai, Shohei Hamada, Shinji Iyama, Koichi Saruwatari, Sho Saeki, Motomichi Takahashi, Tokunori Ikeda, Takuro Sakagami
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Oral microbiota is associated with human diseases including cancer. Emerging evidence suggests that proton pump inhibitors (PPIs), which allow the oral microbiome to translocate into the gut, negatively influence the efficacy of immune checkpoint blo
Externí odkaz:
https://doaj.org/article/0c60a5830111409a90e055b2ff15665d
Autor:
Shohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda, Megumi Inaba, Kosuke Kashiwabara, Tomoki Sadamatsu, Nahoko Sato, Kimitaka Akaike, Hiroko Okabayashi, Koichi Saruwatari, Yusuke Tomita, Sho Saeki, Naomi Hirata, Takeshi Yoshinaga, Kazuhiko Fujii
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Acute exacerbation of interstitial lung disease (AE-ILD) is the most serious complication in lung cancer patients with pre-existing ILD receiving chemotherapy. The role of vascular endothelial growth factor (VEGF) in pathogenesis
Externí odkaz:
https://doaj.org/article/eb958ef0472f4804a85dcb353ff6677e
Autor:
Shohei Hamada, Hidenori Ichiyasu, Megumi Inaba, Hiroshi Takahashi, Tomoki Sadamatsu, Kimitaka Akaike, Aiko Masunaga, Yasumasa Tashiro, Naomi Hirata, Takeshi Yoshinaga, Takuro Sakagami
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Background The increasing incidence of life-threatening Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients is a global concern. Yet, no reports have examined the prognostic significance of pre-existing interstitial lung disease (ILD)
Externí odkaz:
https://doaj.org/article/e8dc1fbb6d4347cc83f740eb465b6e50
Autor:
Hiroko Okabayashi, Hidenori Ichiyasu, Sayuri Hirooka, Kimitaka Akaike, Keisuke Kojima, Takayuki Jodai, Yasumiko Sakamoto, Hideharu Ideguchi, Shohei Hamada, Chieko Yoshida, Susumu Hirosako, Shinichiro Okamoto, Hirotsugu Kohrogi
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Rapidly progressive interstitial pneumonias (RPIPs) associated with clinically amyopathic dermatomyositis (CADM) are highly resistant to therapy and have a poor prognosis. Multimodal therapies, including direct hemoperfusion using
Externí odkaz:
https://doaj.org/article/1116693facb444e2863b3d01bd909143
Autor:
Kimitaka Akaike, Koichi Saruwatari, Ryohei Matsushima, Kosuke Fujino, Jun Morinaga, Seitaro Oda, Hiroshi Takahashi, Shinya Shiraishi, Hiroko Okabayashi, Shohei Hamada, Yusuke Tomita, Aiko Masunaga, Sho Saeki, Koei Ikeda, Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami
Publikováno v:
Journal of Thoracic Disease. 14:3801-3810
Autor:
Takuro Sakagami, Sho Saeki, Shiho Ishizuka, Kimitaka Akaike, Takayuki Jodai, Shinji Iyama, Ryo Sato, Koichi Saruwatari, Shinya Sakata, Tokunori Ikeda, Yusuke Tomita
Association of antibiotic therapy within 60 days before the start of ICI therapy with survival in patients with NSCLC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bfaf13ebf34a99d277673ee7a2c01d
https://doi.org/10.1158/2326-6066.22542345.v1
https://doi.org/10.1158/2326-6066.22542345.v1
Autor:
Takuro Sakagami, Sho Saeki, Shiho Ishizuka, Kimitaka Akaike, Takayuki Jodai, Shinji Iyama, Ryo Sato, Koichi Saruwatari, Shinya Sakata, Tokunori Ikeda, Yusuke Tomita
Cox proportional hazards regression models with inverse probability of treatment weighting using propensity score.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b9676752403c784bf769c72b2e2e29
https://doi.org/10.1158/2326-6066.22542348
https://doi.org/10.1158/2326-6066.22542348
Autor:
Takuro Sakagami, Sho Saeki, Shiho Ishizuka, Kimitaka Akaike, Takayuki Jodai, Shinji Iyama, Ryo Sato, Koichi Saruwatari, Shinya Sakata, Tokunori Ikeda, Yusuke Tomita
Gut dysbiosis caused by antibiotics impairs response to immune checkpoint blockade (ICB). Gut microbiota is becoming an attractive therapeutic target for cancer. The Clostridium butyricum MIYAIRI 588 strain is a probiotic therapy used to improve symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48705177d257bc2e8fc480b382cdc00a
https://doi.org/10.1158/2326-6066.c.6549888.v1
https://doi.org/10.1158/2326-6066.c.6549888.v1